S'abonner

Does intravenous induction dosing among patients undergoing gastrointestinal surgical procedures follow current recommendations: a study of contemporary practice - 21/08/16

Doi : 10.1016/j.jclinane.2016.02.001 
Shamsuddin Akhtar, MD a, , Jia Liu, BS b, Joseph Heng, BA b, Feng Dai, PhD c, Robert B. Schonberger, MD b, Matthew M. Burg, PhD d
a Department of Anesthesiology and Pharmacology, Yale School of Medicine, New Haven, CT 
b Department of Anesthesiology, Yale School of Medicine, New Haven, CT 
c Yale Center for Analytical Sciences, New Haven, CT 
d Departments of Anesthesiology and Internal Medicine, Yale School of Medicine, New Haven, CT 

Corresponding author at: Associate Professor of Anesthesiology and Pharmacology, PO Box 208051, 333 Cedar St, TMP 3, New Haven, CT 06510-8051. Tel.: +1 203 785 2804; fax: +1 203 785 6664.Associate Professor of Anesthesiology and PharmacologyPO Box 208051, 333 Cedar St, TMP 3New HavenCT06510-8051

Abstract

Study objective

It is recommended to correct intravenous induction doses by up to 50% for patients older than 65 years. The objectives were to determine (a) the degree to which anesthesia providers correct induction doses for age and (b) additionally adjust for American Society of Anesthesiologists physical status (ASA-PS) class (severity of illness) and (c) whether postinduction hypotension is more common among patients aged >65.

Design

Retrospective chart review.

Setting

Academic medical center.

Patients

A total of 1869 adult patients receiving general anesthesia for GI surgical procedures from February 2013 to January 2014.

Measurements

Patients were divided into 3 age groups (age <65, 65-79, ≥80 years) and then further stratified into ASA-PS class (I/II vs III/IV). Multiple pairwise comparisons were conducted using Welch t tests for continuous variables to determine whether dosing was different for the older groups vs the younger group; separate analyses were performed within and across ASA-PS class. This approach was also used to determine differences in mean arterial pressure change in the older groups vs the younger group, whereas the rates of hypotension among different age groups were compared by Cochran-Armitage trend test.

Main results

No significant decrease in dosing between age groups was observed for fentanyl and midazolam. For propofol, there was a significantly lower dosing for older patients: 17% for patients aged 65-79 and 29% for those aged >80, which was still in less than the recommendations. An inverse relationship was observed between propofol dosing and ASA-PS class, but no consistent relationship was noted for fentanyl and midazolam. There were a significantly larger drop in mean arterial pressure and a greater likelihood of hypotension following induction in patients aged 65-79 years and >80 years as compared with those aged <65 years.

Conclusions

This study shows that the administered dose of anesthetic induction agents is significantly higher than that recommended for patients older than 65 years. This failure to age-adjust dose may contribute to hypotensive episodes.

Le texte complet de cet article est disponible en PDF.

Highlights

Higher doses of propofol are administered in elderly patients than recommended.
Practitioners do not adjust for fentanyl and midazolam dose in elderly patients.
Propofol dosing decreases with higher ASA-PS class.
No relationship was noted with fentanyl and midazolam dose and ASA class.
There was a larger drop at induction in MAP in patients aged >65yrs.

Le texte complet de cet article est disponible en PDF.

Keywords : Elderly, Gastrointestinal surgery, Geriatric anesthesia, Hypotension, Intravenous anesthetics, Octagenarians, Propofol


Plan


 Declaration of conflict of interests: SA, JL, JH, FD, RS, and MB declare no conflicts of interests.
☆☆ Disclosure: This work was supported in part by Clinical and Translational Science Award grant UL1 RR024139 from the National Center for Advancing Translational Sciences at the National Institutes of Health. The content is solely the responsibility of the authors and does not necessarily represent the policy or views of the National Institutes of Health or the United States government.


© 2016  Elsevier Inc. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 33

P. 208-215 - septembre 2016 Retour au numéro
Article précédent Article précédent
  • Time-dependent changes in epidural catheter aspirate after injection of a local anesthetic
  • Etsuyo Hori, Tadayoshi Kurita, Shigehito Sato
| Article suivant Article suivant
  • Muscle relaxant facilitates i-gel insertion by novice doctors: A prospective randomized controlled trial
  • Kazuo Hattori, Nobuyasu Komasawa, Yu Miyazaki, Haruki Kido, Shiho Deguchi, Toshiaki Minami

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Elsevier s'engage à rendre ses eBooks accessibles et à se conformer aux lois applicables. Compte tenu de notre vaste bibliothèque de titres, il existe des cas où rendre un livre électronique entièrement accessible présente des défis uniques et l'inclusion de fonctionnalités complètes pourrait transformer sa nature au point de ne plus servir son objectif principal ou d'entraîner un fardeau disproportionné pour l'éditeur. Par conséquent, l'accessibilité de cet eBook peut être limitée. Voir plus

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2026 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.